180 related articles for article (PubMed ID: 1357894)
1. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.
Hansen K; Hovmark A; Lebech AM; Lebech K; Olsson I; Halkier-Sørensen L; Olsson E; Asbrink E
Acta Derm Venereol; 1992 Aug; 72(4):297-300. PubMed ID: 1357894
[TBL] [Abstract][Full Text] [Related]
2. Treatment and course of erythema chronicum migrans.
Neumann R; Aberer E; Stanek G
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):372-6. PubMed ID: 3109145
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Anaplasma phagocytophilum presence in early Lyme borreliosis manifested by erythema migrans skin lesions.
Moniuszko-Malinowska A; Dunaj J; Andersson MO; Czupryna P; Zajkowska J; Guziejko K; Garkowski A; Grygorczuk S; Kondrusik M; Pancewicz S
Travel Med Infect Dis; 2020; 36():101648. PubMed ID: 32247015
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis.
Weber K; Wilske B; Preac-Mursic V; Thurmayr R
Infection; 1993; 21(6):367-72. PubMed ID: 8132365
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of erythema migrans after treatment with phenoxymethyl penicillin.
Bennet L; Danell S; Berglund J
Scand J Infect Dis; 2003; 35(2):129-31. PubMed ID: 12693565
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
Arnez M; Radsel-Medvescek A; Pleterski-Rigler D; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):916-22. PubMed ID: 10666802
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.
Berger BW; Johnson RC
J Am Acad Dermatol; 1989 Dec; 21(6):1188-91. PubMed ID: 2511231
[TBL] [Abstract][Full Text] [Related]
8. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
Breier F; Kunz G; Klade H; Stanek G; Aberer E
Infection; 1996; 24(1):69-72. PubMed ID: 8852474
[TBL] [Abstract][Full Text] [Related]
9. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
10. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study.
Nadelman RB; Nowakowski J; Forseter G; Bittker S; Cooper D; Goldberg N; McKenna D; Wormser GP
Am J Med; 1993 Jun; 94(6):583-8. PubMed ID: 8506882
[TBL] [Abstract][Full Text] [Related]
11. [Clinical manifestations, diagnosis and treatment of Lyme borreliosis].
Ocias LF; Jensen BB; Knudtzen FC; Skarphedinsson S; Dessau RB
Ugeskr Laeger; 2017 May; 179(18):. PubMed ID: 28473022
[TBL] [Abstract][Full Text] [Related]
12. Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial.
Stupica D; Collinet-Adler S; Blagus R; Gomišček A; Cerar Kišek T; Ružić-Sabljić E; Velušček M
Lancet Infect Dis; 2023 Mar; 23(3):371-379. PubMed ID: 36209759
[TBL] [Abstract][Full Text] [Related]
13. [First-choice treatment for erythema migrans is still penicillin].
Eliassen KE; Lindbaek M; Berild D; Hjortdahl P; Fetveit A
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1681; author reply 1681. PubMed ID: 18704139
[No Abstract] [Full Text] [Related]
14. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
Egberts F; Möller M; Proksch E; Schwarz T
J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden.
Ornstein K; Berglund J; Nilsson I; Norrby R; Bergström S
J Clin Microbiol; 2001 Apr; 39(4):1294-8. PubMed ID: 11283044
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure in erythema migrans--a review.
Weber K
Infection; 1996; 24(1):73-5. PubMed ID: 8852475
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
Smith RP; Schoen RT; Rahn DW; Sikand VK; Nowakowski J; Parenti DL; Holman MS; Persing DH; Steere AC
Ann Intern Med; 2002 Mar; 136(6):421-8. PubMed ID: 11900494
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of Lyme borreliosis.
Aberer E; Klade H
Infection; 1991; 19(4):284-6. PubMed ID: 1917047
[TBL] [Abstract][Full Text] [Related]
19. Therapy of Lyme borreliosis in children.
Krbkova L; Stanek G
Infection; 1996; 24(2):170-3. PubMed ID: 8740116
[TBL] [Abstract][Full Text] [Related]
20. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
